New laser could ease glaucoma without drops

NCT ID NCT05902871

Ongoing Disease control Sponsor: BelkinVision Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new laser procedure called Direct Selective Laser Trabeculoplasty (DSLT) in 40 ethnic Chinese patients with glaucoma or high eye pressure. The laser aims to improve fluid drainage in the eye and reduce pressure. Researchers will check if the treatment is safe and effective over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Direct Selective Laser Trabeculoplasty (DSLT) using the Eagle device
What this could lead to: If successful, this could offer a safe, quick laser treatment to lower eye pressure and help manage glaucoma without daily eye drops.
What could go wrong: This is a small, early-stage study with only 40 participants. Results may not apply to all glaucoma patients, and long-term safety and effectiveness are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NORMAL TENSION GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma low tension glaucoma ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NORMAL TENSION GLAUCOMA OCULAR HYPERTENSION PRIMARY OPEN ANGLE GLAUCOMA

Contacts and locations

Locations

C-Mer Eye Clinic

Hong Kong, China
SERI

Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.